Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001362971 | SCV001559037 | likely benign | Multiple gastrointestinal atresias | 2024-05-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003169816 | SCV003864270 | uncertain significance | Inborn genetic diseases | 2023-03-07 | criteria provided, single submitter | clinical testing | The c.1603A>T (p.I535F) alteration is located in exon 14 (coding exon 14) of the TTC7A gene. This alteration results from a A to T substitution at nucleotide position 1603, causing the isoleucine (I) at amino acid position 535 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |